Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SCYNEXIS, Inc. - Common Stock (NQ:SCYX)

0.7380 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 184
Open 0.7380
Bid (Size) 0.7110 (20)
Ask (Size) 0.7380 (119)
Prev. Close 0.7380
Today's Range 0.7380 - 0.7380
52wk Range 0.6600 - 2.260
Shares Outstanding 37,175,665
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The market is filled with gapping stocks in Friday's session.
Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
Via Chartmill
SCYX Stock Earnings: SCYNEXIS Misses EPS, Misses Revenue for Q2 2024
SCYX stock results show that SCYNEXIS missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
-49.1%
-49.1%
1 Month
-0.4%
-0.4%
3 Month
-30.7%
-30.7%
6 Month
-31.7%
-31.7%
1 Year
-63.5%
-63.5%

More News

Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
3 Stocks Under $10 With the Potential for Massive Gains
Via InvestorPlace
Should you consider SCYNEXIS INC (NASDAQ:SCYX) for growth investing?
Via Chartmill
3 Dirt-Cheap Drug Developers With Blockbuster Potential
Via InvestorPlace
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
Via InvestorPlace
Hidden Gems: 3 Under-$10 Stocks Poised for 500% Growth by 2025
Via InvestorPlace
3 Stocks Under $10 With Mammoth Growth Prospects
Via InvestorPlace
SCYX Stock Earnings: SCYNEXIS Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
SCYX Stock Earnings: SCYNEXIS Misses EPS, Beats Revenue for Q4 2023
Via InvestorPlace
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
SCYX DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages SCYNEXIS, Inc. Investors with Losses to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX
Via NewMediaWire
Topics Lawsuit Product Recall
A Look Into Healthcare Sector Value Stocks
Via Benzinga
SCYX DEADLINE ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action – SCYX
From The Rosen Law Firm PA
Via GlobeNewswire
SCYNEXIS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against SCYNEXIS, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
SCYNEXIS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Scynexis To Contact Him Directly To Discuss Their Options
From Faruqi & Faruqi LLP
Via GlobeNewswire
SCYX DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX
Via NewMediaWire
Topics Lawsuit Product Recall
Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SCYNEXIS, Li-Cycle, and FMC and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
SCYX IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action – SCYX
From The Rosen Law Firm PA
Via GlobeNewswire
SCYX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action – SCYX
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SCYNEXIS, Li-Cycle, and FMC and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Frequently Asked Questions

Is SCYNEXIS, Inc. - Common Stock publicly traded?
Yes, SCYNEXIS, Inc. - Common Stock is publicly traded.
What exchange does SCYNEXIS, Inc. - Common Stock trade on?
SCYNEXIS, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for SCYNEXIS, Inc. - Common Stock?
The ticker symbol for SCYNEXIS, Inc. - Common Stock is SCYX on the Nasdaq Stock Market
What is the current price of SCYNEXIS, Inc. - Common Stock?
The current price of SCYNEXIS, Inc. - Common Stock is 0.7380
When was SCYNEXIS, Inc. - Common Stock last traded?
The last trade of SCYNEXIS, Inc. - Common Stock was at 07/24/25 04:00 PM ET
What is the market capitalization of SCYNEXIS, Inc. - Common Stock?
The market capitalization of SCYNEXIS, Inc. - Common Stock is 27.44M
How many shares of SCYNEXIS, Inc. - Common Stock are outstanding?
SCYNEXIS, Inc. - Common Stock has 27M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.